Deerfield, Ill.-based Baxter International, a global, diversified healthcare company, has entered into a definitive agreement with ApaTech, a private equity-backed, U.K.-based orthobiologic products company, in which Baxter will acquire all of the outstanding equity of ApaTech for total consideration of…
Uncategorized
George Steven Kooshian, an AIDS physician based in La Quinta, Calif., was sentenced to 15 months in federal prison after pleading guilty to federal healthcare fraud charges for "subdosing" patients by administering doses of medicine that contained less than the…
UnitedHealthcare and Aetna have reversed their spinal procedure policies to cover Xtreme Lateral Interbody Fusion, or XLIF, according to news releases from NuVasive, a medical device company focused on developing products for minimally invasive spine surgery.
Although a 21.2 percent physician fee cut is going into effect today, CMS has instructed Medicare contractors to hold claims for the first 10 business days to allow Congress time to pass a fee fix, according to a release by…
Michael Behr, MD, an orthopedic surgeon in Fayette, Ga., south of Atlanta, likes the convenience of walking directly into his own ASC after working over at the hospital.
Advertisement
Joint Replacement Hospitals of America plans to construct a joint replacement center in Buellton, Calif., according to a report by the Santa Ynez Valley Journal.
A bill that would permit physicians only to administer pain management injections into a patient's neck or spinal area passed the Oklahoma House by a vote of 55-33, split mostly on urban and rural lines, according to a report in…
1. Its very unlikely that President Obama gained any Republican votes through his most recent healthcare summit and efforts on healthcare reform. President Obama's more than seven hour healthcare summit yesterday most likely did not win over any Republicans in…
Forty-four Democratic senators are urging Senate Majority Leader Harry Reid to introduce a bill that would extend enhanced Medicaid funding to the states after the end of the year, according to a report by AHA News Now.
The U.S. Food and Drug Administration and the National Institutes of Health have announced an initiative designed to accelerate the process from scientific breakthrough to the availability of new, innovative medical therapies for patients, according to an FDA news release.